To study the association of GLP1-RA use with pancreatic cancer incidence, we used a Cox regression model with time varying covariates, an analysis that is free from the typical biases caused by restricting the study population according to strict inclusion criteria and that provides excellent external validity. Here, GLP1R is linked to familial pancreatic carcinoma.